Concepedia

Publication | Closed Access

Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.

71

Citations

0

References

1998

Year

D B Hunninghake, Rebecca G. Bakker-Arkema, J P Wigand, Margaret Drehobl, Helmut G. Schrott, J L Early, Pauline Abdallah, Scott McBride, D M Black
PubMed

Abstract

At the starting dose, a significantly (P < .05) greater percentage of atorvastatin-treated patients at risk for CHD reached the target LDL cholesterol concentration than patients with treated with other reductase inhibitors.